Ondine Biomedical (LON:OBI) Stock Price Down 2.4% – Here’s What Happened

Ondine Biomedical Inc. (LON:OBI)’s share price dropped 2.4% on Wednesday . The stock traded as low as C$10.00 and last traded at C$10.00. Approximately 6,261 shares traded hands during trading, a decline of 98% from the average daily volume of 313,582 shares. The stock had previously closed at C$10.25.

Ondine Biomedical Stock Performance

The company’s 50-day moving average price is C$11.30 and its two-hundred day moving average price is C$8.94. The stock has a market cap of C$71.90 million, a PE ratio of -3.01 and a beta of 0.10. The company has a debt-to-equity ratio of 25.95, a quick ratio of 8.26 and a current ratio of 1.36.

Insider Buying and Selling at Ondine Biomedical

In other Ondine Biomedical news, insider Carolyn Cross purchased 149,225 shares of the stock in a transaction on Monday, February 3rd. The stock was acquired at an average cost of C$13.00 per share, with a total value of C$1,939,925.00. Company insiders own 36.69% of the company’s stock.

About Ondine Biomedical

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.